Oncotelic Therapeutics, Inc. (OTLC) › Shares OutstandingOncotelic Therapeutics, Inc. (OTLC) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2010: 5.50M2011: 1.26M2012: 1.75M2013: 5.59M2014: 20.70M2015: 26.55M2016: 26.55M2017: 26.55M2018: 6.84M2019: 84.07M2020: 90.60M2021: 375.29M2022: 391.85M2023: 399.18M2024: 407.29M2025: 442.60M442.60M2010Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025442.60M+8.7%2024407.29M+2.0%2023399.18M+1.9%2022391.85M+4.4%2021375.29M+314.2%202090.60M+7.8%201984.07M+1128.4%20186.84M-74.2%201726.55M+0.0%201626.55M+0.0%201526.55M+28.2%201420.70M+270.7%20135.59M+219.9%20121.75M+38.0%20111.26M-77.0%20105.50M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share